Results 81 to 90 of about 5,629 (238)

Incidence and Prognostic Implications of Lymphovascular Invasion in Node‐Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group

Journal of Surgical Oncology, Volume 131, Issue 3, Page 465-472, March 2025.
ABSTRACT Background Despite the well‐known prognostic role of lymph node metastasis (LNM) in pNETs, less is known about the importance of lymphovascular invasion (LVI) among patients with these tumors. Methods Patients undergoing pancreatectomy for pNET between 2002 and 2020 were identified in the US Neuroendocrine Tumor Study Group database.
Kota Sahara, Diamantis I. Tsilimigras, Yuki Homma, Jun Kawashima, Shishir K. Maithel, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, George A. Poultsides, Cliff Cho, Itaru Endo, Timothy M. Pawlik   +12 more
wiley   +1 more source

Zollinger–Ellison syndrome in a 12-year-old child

Journal of Indian Association of Pediatric Surgeons, 2017
The syndrome described by Zollinger and Ellison in 1955 is a rare clinical entity which is even rarer in children. This report describes a 12-year-old boy who presented with refractory peptic ulcer disease which was finally diagnosed to be due to a ...
Abir Lal Nath, Nandita A Saxena, Bharati K Kulkarni, Shyam S Borwankar, Hemant N Lahoti, Sanjay N Oak   +5 more
doaj   +1 more source

Human insulinoma: Clinical, cellular, and molecular aspects [PDF]

, 2018
Insulinoma is the most frequently encountered functioning endocrine pancreatic tumor in humans. In this overview we summarize morphological and clinical features of insulinomas, report about the proinsulin-insulin conversion in normal and neoplastic B ...
Heitz, Philipp, Komminoth, Paul, Roth, Jürgen   +2 more
core  

Vergleich Gastrinrezeptorszintigraphie mit 111-In-DTPA-D-Glu1-Minigastrin versus Somatostatinrezeptorszintigraphie mit 111-In-DTPA-D-Phe1-Octreotid bei Patienten mit neuroendokrinen Tumoren. [PDF]

, 2006
60 Patienten mit neuroendokrinen Tumoren erhielten sowohl eine Somatostatinrezeptorszintigraphie (SRS) als auch eine Gastrinrezeptorszintigraphie mit (GRS) (51 Karzinoide, 3 Gastrinome, 2 Glukagonome, 1 Insulinom, 3 Paragangliome).
Behr, T.M. (Prof. Dr.), Graß, Julia
core   +1 more source

Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours

Journal of Neuroendocrinology, Volume 37, Issue 3, March 2025.
Abstract Peptide receptor radionuclide therapy (PRRT) using [177Lu‐DOTA0,Tyr3]octreotate (177Lu‐DOTATATE) represents an established treatment modality for somatostatin receptor‐positive, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumours (GEP NET) of grade 1 or 2.
Jelka Kuiper, Eline Zoetelief, Tessa Brabander, Wouter W. de Herder, Johannes Hofland   +4 more
wiley   +1 more source

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours [PDF]

, 2017
Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements.
Caplin, Martyn, Falconi, Massimo, Fusai, Giuseppe K., Lykoudis, Panagis M., Muffatti, Francesca, Partelli, Stefano, Rugge, Massimo   +6 more
core   +1 more source

Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020

Pediatric Blood &Cancer, Volume 72, Issue 2, February 2025.
ABSTRACT Background Neuroendocrine tumors (NETs), although rare, are considered one of the most common gastrointestinal and bronchopulmonary pediatric neoplasms. We aimed to determine the incidence, tumor characteristics, management, and outcome of NETs and explore the role of genetic predisposition, focusing on low and intermediate grade tumors ...
Mona P. Ankerstjerne, Sara Giovannoni, Lene G. Christensen, Sören Möller, Pernille Holmager, Ulrich Knigge, Mark B. Ellebaek, Mathias Rathe   +7 more
wiley   +1 more source

Gastrinoma

, 2021
null Dan G. Gridley, MD, null Albert Roh, MD, null Joshua Rabang   +2 more
  +5 more sources

Clinical intestinal transplantation: New perspectives and immunologic considerations [PDF]

, 1998
Background: Although tacrolimus-based immunosuppression has made intestinal transplantation feasible, the risk of the requisite chronic high- dose treatment has inhibited the widespread use of these procedures.
Abu-Elmagd, K, Bueno, J, Demetris, J, Fawzy, AT, Fung, JJ, Furukawa, H, Irish, W, Lee, R, McMichael, J, Murase, N, Rakela, J, Rao, A, Reyes, J, Starzl, TE, Todo, S   +14 more
core   +1 more source

How to treat gastrinomas in patients with multiple endocrine neoplasia type1: surgery or long-term proton pump inhibitors? [PDF]

, 2022
Masayuki Imamura, Izumi Komoto, Yoshiro Taki   +2 more
openalex   +1 more source